In Situ and Real‐Time Multi‐Modality Imaging Guided Orderly Triple‐Therapy of Tumors with a Multifunctional Nanodrug
Advanced Science · 2025
DOI: 10.1002/advs.202501048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Chaoyi Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, P. …. Hauptthemen laut MEDLINE: Prodrugs, Multimodal Imaging, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Effective integration of different therapeutic methods is a promising way to improve the overall efficacy of tumor therapy, which needs to be guided by in situ and real‐time monitoring of each therapeutic process. Here a multifunctional AuNR@SiO 2 @MnO 2 @DNA prodrugs (ASMD) nanodrug is designed for orderly photothermal therapy (PTT)/chemodynamic therapy (CDT)/gene therapy (GT) triple‐therapy of tumors, which can be guided by the in situ and real‐time photoacoustic (PA)/magnetic resonance (MR)/fluorescence (FL) multi‐modality imaging. The gold nanorod in ASMD can generate a PA signal and perform PTT. The MnO 2 in ASMD can respond to the glutathione inside tumor cells to release Mn 2+ , which can generate MR signal and perform CDT by catalyzing the degradation of intracellular H 2 O 2 to generate · OH. The DNA prodrugs can perform a cascade response in the presence of the released Mn 2+ and the intracellular microRNA 21, which can turn on the quenched FL signal and release small‐interfering RNA and antisense oligonucleotide to perform GT. Guiding by the in situ and real‐time PA/MR/FL multi‐modality imaging of each therapeutic process, an orderly PTT/CDT/GT triple‐therapy of tumors is established, which provides a significant and promising strategy to develop more efficient and practical therapeutic programs for tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, P. R. China.
ORCID-Profile: Yunlong Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, C., Meng, Y., An, Y., Jia, J., Wang, Y., Li, G., Li, Y., Wu, S., Geng, C., Chen, Y., & Ju, H. (2025). In Situ and Real‐Time Multi‐Modality Imaging Guided Orderly Triple‐Therapy of Tumors with a Multifunctional Nanodrug. Advanced Science. https://doi.org/10.1002/advs.202501048
Vancouver
Yang C, Meng Y, An Y, Jia J, Wang Y, Li G, et al. In Situ and Real‐Time Multi‐Modality Imaging Guided Orderly Triple‐Therapy of Tumors with a Multifunctional Nanodrug. Advanced Science. 2025. doi:10.1002/advs.202501048
BibTeX
@article{Yang2025,
author = {Yang, Chaoyi and Meng, Yuexuan and An, Ying and Jia, Jing and Wang, Yuru and Li, Guangming and Li, Yiran and Wu, Shan and Geng, Chengyao and Chen, Yunlong and Ju, Huangxian},
title = {In Situ and Real‐Time Multi‐Modality Imaging Guided Orderly Triple‐Therapy of Tumors with a Multifunctional Nanodrug},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202501048}
}
EUVIMED